The 5 tumors with the highest BCL2 protein expression had concurrent expression of at least 1 neuroendocrine marker; 3 were identified as small-cell carcinomas and 2 as large-cell neuroendocrine carcinomas (Figure 5, A and B, and Supplemental Table 13). The gene discussed is BCL2; the disease is large cell neuroendocrine carcinoma.